|
Simone Mok, Emma Roycroft, Peter R Flanagan, Lorraine Montgomery, Emanuele Borroni, Thomas R Rogers, Margaret M Fitzgibbon, Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis isolates, Antimicrobial Agents and Chemotherapy, 2021,
Journal Article,
PUBLISHED
DOI
|
|
Roycroft E, Fitzgibbon MM, Kelly DM, Scully M, McLaughlin AM, Flanagan PR, Gordon SV, Rogers TR, Keane J, O Meara M, The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing., The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021,
Journal Article,
PUBLISHED
DOI
|
|
Fitzgibbon MM, Roycroft E, Sheehan G, Mc Laughlin AM, Quintyne KI, Brabazon E, O'Meara M, Flanagan PR, Seagar AL, Laurenson IF, Keane J, Rogers TR., False detection of rifampicin resistance using Xpert® MTB/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis., JAC Antimicrob Resist, 3, (3), 2021, pdlab101 ,
Journal Article,
PUBLISHED
DOI
|
|
Tagliani E, Anthony R, Kohl TA, de Neeling A, Nikolayevskyy V, Ködmön C, Maurer FP, Niemann S, van Soolingen D, van der Werf MJ, Cirillo DM, ECDC molecular surveillance project participants, Use of a Whole Genome Sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study., The European respiratory journal, 2020,
Journal Article,
PUBLISHED
|
|
Redondo N, Mok S, Montgomery L, Flanagan PR, McNamara E, Smyth EG, O'Sullivan N, Schaffer K, Rogers TR, Fitzgibbon MM, Genomic Analysis of Mycobacterium abscessus Complex Isolates Collected in Ireland between 2006 and 2017., Journal of clinical microbiology, 2020,
Journal Article,
PUBLISHED
|
|
, Impact of COVID-19 pandemic on tuberculosis laboratory services in Europe., The European respiratory journal, 2020,
Journal Article,
PUBLISHED
DOI
|
|
Mok S, Hannan MM, Nölke L, Stapleton P, O'Sullivan N, Murphy P, McLaughlin AM, McNamara E, Fitzgibbon MM, Rogers TR, Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates., Antimicrobial agents and chemotherapy, 2019,
Journal Article,
PUBLISHED
|
|
Roycroft E, O'Toole RF, Fitzgibbon MM, Montgomery L, O'Meara M, Downes P, Jackson S, O'Donnell J, Laurenson IF, McLaughlin AM, Keane J, Rogers TR., Molecular epidemiology of multi- and extensively-drug-resistant mycobacterium tuberculosis in ireland, 2001-2014., The Journal of infection, 76, (1), 2018, p55-67 ,
Journal Article,
PUBLISHED
DOI
|
|
Mok S, Rogers TR , Fitzgibbon M., Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera., Journal of Clinical Microbiology, 55, (6), 2017, p1821 - 1826,
Notes: [DOI: 10.1128/JCM.00009-17 PMID:28356415],
Journal Article,
PUBLISHED
|
|
Gonzalo X, Claxton P, Brown T, Montgomery L, Fitzgibbon M, Laurenson I, Drobniewski F, True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillance., Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016,
Journal Article,
PUBLISHED
|
|
|
